EN 中文
Home Strategic Partnerships News Contact us
TOTAL:64 NEWS
Zhaoke Ophthalmology Announces the Completion of NVK002 Phase III Mini-CHAMP Last Patient Last Visit in China
read
2023-08-09
1439
Zhaoke Ophthalmology Establishes Strategic Partnership with Eyebright Medical
read
2023-08-02
1326
Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer™ for the Treatment of Dry Eye Disease
read
2023-06-08
1430
Zhaoke Ophthalmology’s Partner Vyluma Announces FDA Acceptance of New Drug Application for NVK002, its Novel Investigational Treatment for Pediatric Myopia
read
2023-06-07
1599
Zhaoke Ophthalmology’s Partner Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL PF™ for the Treatment of Presbyopia
read
2023-04-25
1287
>

Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat